Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The International Center for Cell Therapy & Cancer (ICCTC) is a specialized medical and research institution focused on the development and clinical application of advanced cellular immunotherapies. The center provides a range of personalized treatments, including dendritic cell vaccines, natural killer (NK) cell therapies, and cytokine-induced killer (CIK) cell therapies, primarily targeting various forms of cancer and immune-related disorders. ICCTC integrates laboratory research with clinical practice to offer regenerative medicine and oncology solutions that aim to enhance the body's natural immune response against malignant cells. The organization operates internationally, often collaborating with regional clinics to provide access to next-generation biological therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on International Center for Cell Therapy & Cancer.